指南与共识慢阻肺

无创通气与经鼻高流量治疗期间的气溶胶治疗:当前技术与共识推荐

Aerosol therapy during noninvasive ventilation (NIV) and nasal high-flow therapy (HFT): current technology and consensus-based recommendations
RSS 订阅 · 指南共识 · 呼吸支持与睡眠 · 2026-06-19

结果显示,振动网孔雾化器(VMN)在HFT和NIV下的肺沉积优于喷射雾化器(JN);JN适用于无VMN、需雾化高黏度药液或预算受限时。雾化器选择应个体化,兼顾技术、临床与经济需求。

要点

  • HFT和NIV下使用VMN的肺沉积优于JN。
  • 无VMN、高黏度药液或预算受限时可选用JN。
  • 雾化器选择应个体化,结合技术、临床和经济要求。

核心结论

  • 在HFT和NIV期间,VMN雾化给药的肺沉积优于JN。
  • JN适用于无VMN可用、需雾化高黏度药液或存在预算限制的情形。
  • 雾化系统的选择和应用应个体化,与适应证一致,并考虑技术、临床和经济要求。

研究设计与样本

  • 由肺科医生和重症监护医生组成的跨学科专家小组制定实践导向推荐。
  • 纳入临床研究、综述、指南文件和技术报告,并评估证据等级。
  • 推荐经多阶段流程达成共识。

主要发现

  • HFT和NIV下使用VMN进行气溶胶给药,肺沉积优于使用JN。
  • JN在无VMN、需雾化高黏度药液或预算受限时适用。

关键数值与推荐

  • 推荐条款:HFT和NIV下优先考虑VMN以获得更好的肺沉积。
  • 推荐条款:无VMN、高黏度药液或预算受限时可选用JN。
  • 推荐条款:雾化器选择应个体化,结合技术、临床和经济要求。

临床怎么用

  • 在HFT或NIV患者进行气溶胶治疗时,优先选择VMN以优化肺沉积。
  • 当VMN不可及、药液黏度高或预算受限时,可改用JN。
  • 根据患者适应证及技术、临床、经济条件个体化选择雾化系统。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Pneumologie. 2026 Jun 19. doi: 10.1055/a-2873-9563. Online ahead of print. ABSTRACT BACKGROUND: Aerosol therapy is an essential procedure in the treatment of acute and chronic respiratory diseases. Currently, there are no up-to-date guidelines from German-speaking countries on the selection and use of nebulizer systems in patients undergoing high-flow therapy via nasal cannula (HFT) and non-invasive ventilation (NIV). METHODS: An interdisciplinary panel of experts consisting of pulmonologists and intensive care physicians developed practice-oriented recommendations for aerosol therapy under HFT and NIV. The evidence base was derived from a systematic search of the PubMed database of the US National Library of Medicine up to and including November 2025.Publications on clinical studies, reviews, guideline documents, and technical reports were included. The respective level of evidence of the information was evaluated. The recommendations were agreed upon in a multi-stage process. RESULTS: Aerosol administration under HFT and NIV with a vibrating mesh nebulizer (VMN) achieved better lung deposition compared to the use of a jet nebulizer (JN). A JN is suitable if VMNs are not available, if highly viscous drug solutions are to be nebulized, or if there are budgetary limitations. CONCLUSION: The choice and application of the nebulizer system should be patient-specific, consistent with the indication, taking into account technical, clinical, and economic requirements. PMID: 42320581 | DOI: 10.1055/a-2873-9563

来源:指南共识 · 呼吸支持与睡眠,查看原文。版权归原作者所有。

引用

  1. 指南共识 · 呼吸支持与睡眠:Aerosol therapy during noninvasive ventilation (NIV) and nasal high-flow therapy (HFT): current technology and consensus-based recommendations

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。